Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Evidence-Based Approaches for Accelerating Patient Enrollment in Oncology


Date: Wednesday, May 24, 2017

Time: 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)

Duration: 60 minutes

Featured Speakers:

  • Caroline Morvan-Beccavin, PhD, Executive Director, Global Portfolio Oversight, Oncology Covance
  • Michelle Jones, Senior Director, Clinical Informatics, Clinical Business Informatics & Solutions, Covance

The number of oncology clinical trials has increased exponentially in recent years, putting ever more pressure on increasing clinical trial efficiency by reducing costs and timelines. Patient recruitment swallows 40% of trial costs, yet only 10–17% of studies enroll on time and approximately 11% of sites in any given study fail to enroll a single patient.

The excessive amount of time taken for patient recruitment, which can reach 60% of the total trial time, can be drastically reduced by identifying experienced investigators, ensuring access to specific patient pools and seeking sufficient infrastructure for optimal trial execution.

Join this webinar as Covance highlights proven solutions for overcoming the enormous challenge of study planning and patient recruitment. Also, learn more about how the Covance informatics platform solves patient recruitment challenges by using strategic, evidence-based methodologies. Xcellerate® Trial Design is the most extensive knowledgebase in the industry, making powerful use of a combination of LabCorp and Covance data on over 13 billion lab tests, 142 million de-identified patients from over 750K heathcare providers in Labcorp; 175,000 unique investigators and over 15,000 protocols in CLS. These approaches are proven to accelerate patient enrollment, reduce the proportion of non-recruiting sites leading to shorter timelines and reduced costs.

Keywords: Clinical Trials, Oncology, Patient Enrollment


    Caroline Morvan-Beccavin, PhD, Executive Director, Global Portfolio Oversight, Oncology, Covance

    Dr. Morvan-Beccavin leads high quality end-to-end business development strategies at Covance to help drive and implement therapeutic area-specific initiatives and achieve results in global, virtual and complex environments. She has worked with Covance since 2006, starting with global clinical trial management where she controlled a portfolio of Phase I-IV clinical trials from setup to closure, mainly in oncology, infectious and cardiovascular diseases for a wide variety of pharmaceutical companies.

    Michelle Jones, Senior Director, Clinical Informatics, Clinical Business Informatics & Solutions, Covance

    Michelle is the global leader for the Clinical Informatics group within Covance Development Services. She is responsible for the provision of recruitment timeline and endpoint forecasts for all Phase II and III clinical trials, data flow forecasts and reconciliation tools. Michelle as over 20 years of experience including a background in statistics.


    Senior level professionals involved in oncology clinical trials. Relevant job areas include:

    • Information Management
    • Information Technology
    • Operations
    • Research & Development
    • Strategy Planning

    Covance is one of the world's largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion and more than 12,000 employees in more than 60 countries. 

    Share this webinar with your colleagues!

    Copyright © 2016-2017 Honeycomb Worldwide Inc.